Cargando…
Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to az...
Autores principales: | Hong, Kevin Cyrus, Schachter, Julius, Moncada, Jeanne, Zhou, Zhaoxia, House, Jenafir, Lietman, Thomas M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744222/ https://www.ncbi.nlm.nih.gov/pubmed/19624926 http://dx.doi.org/10.3201/eid1507.081563 |
Ejemplares similares
-
Risk Factors for Ocular Chlamydia after Three Mass Azithromycin Distributions
por: Ayele, Berhan, et al.
Publicado: (2011) -
Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022) -
Typing of Lymphogranuloma Venereum Chlamydia trachomatis Strains
por: Christerson, Linus, et al.
Publicado: (2010) -
Eliminating Trachoma in Areas with Limited Disease
por: Gaynor, Bruce D., et al.
Publicado: (2003) -
Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)